High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphoma

Published:2016-07-29 Issue:6 Volume:178 Page:991-994
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Cheah Chan Yoon¹²^ORCID,Joske David¹²,Cull Gavin¹²,Gilbertson Michael³⁴,Opat Stephen S.³⁴,Tam Constantine S.⁵⁶,Wirth Andrew⁶⁷,Seymour John F.⁵⁶

Affiliation:

1. Department of Haematology; Sir Charles Gairdner Hospital and Pathwest Laboratory Medicine WA; Nedlands Western Australia Australia

2. University of Western Australia; Crawley Western Australia Australia

3. Department of Haematology; Monash Medical Centre; Clayton Victoria Australia

4. Monash University; Clayton Victoria Australia

5. Peter MacCallum Cancer Centre; St Andrews Place; East Melbourne Victoria Australia

6. University of Melbourne; Parkville Victoria Australia

7. Division of Radiation Oncology; Peter MacCallum Cancer Centre; St Andrews Place; East Melbourne Victoria Australia

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14187/fullpdf

Reference10 articles.

1. Central nervous system prophylaxis in non-Hodgkin lymphoma: who, what, and when?;Cheah;Current Oncology Reports,2015

2. A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma;Cheah;British Journal of Cancer,2014

3. Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma;Chen;Cancer,2015

4. Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC network;Damaj;Haematologica,2015

5. High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem-cell transplantation in patients with systemic B-cell lymphoma and secondary CNS involvement: final results of a multicenter phase II trial;Ferreri;Journal of Clinical Oncology,2015a

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy;Leukemia & Lymphoma;2023-12-22

2. A novel Bruton's tyrosine kinase inhibitor JDB175 shows potent efficacy to suppress central nervous system lymphoma;MedComm;2023-11-04

3. Real-world experiences of CNS-directed chemotherapy followed by autologous stem cell transplantation for secondary CNS involvement in relapsed or refractory diffuse large B-cell lymphoma;Frontiers in Oncology;2023-01-19

4. Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective study;Therapeutic Advances in Hematology;2022-01

5. Efficacy and Safety of Axicabtagene Ciloleucel and Tisagenlecleucel Administration in Lymphoma Patients With Secondary CNS Involvement: A Systematic Review;Frontiers in Immunology;2021-07-05